Skip to main content

Table 3 Maternal factors associated with pooled placental malaria in univariate analysis

From: Age-modified factors associated with placental malaria in rural Burkina Faso

Factors

Pooled placental* malaria

[n / N (%)]

OR (95 % CI)

Age (years)

  

  < 30

538 / 588 (91.5)

4.74 (3.03 - 7.40)

  ≥ 30

109 / 157 (69.4)

1

Gravidity†

  

  ≤ 2

343 / 355 (96.6)

8.09 (4.34 - 15.08)

  > 2

304 / 390 (77.9)

1

Bednet use the previous night

  

  Not used

324 / 370 (87.6)

1.13 (0.74 – 1.74)

  Used

323 / 375 (86.1)

1

Received IPTp before study start

  

  Yes

89 / 97 (91.8)

1.79 (0.84 - 3.82)

  No

558 / 648 (86.1)

1

Anemia at study start (Hb < 11g/dl)

  

  Yes

492 / 553 (89.0)

1.93 (1.23 - 3.01)

  No

155 / 192 (80.7)

1

Underweight at study start (BMI <18.5kg/m2)

  

  Yes

43 / 46 (93.5)

2.25 (0.69 - 7.41)

  No

604 / 699 (86.4)

1

Symptomatic malaria at study start†

  

  Yes

284 / 308 (92.2)

2.42 (1.49 - 3.93)

  No

362 / 436 (83.0)

1

Treatment at random†

  

  AL

213 / 242 (88.0)

1.34 (0.79 - 2.25)

  ASAQ

224 / 255 (87.8)

1.31 (0.79 - 2.19)

  MQAS

209 / 247 (84.6)

1

Recurrent malaria during follow-up†

  

  Yes

270 / 289 (93.4)

2.99 (1.77 - 5.06)

  No

375 / 454 (82.6)

1

Season at delivery

  

  Rainy

412 / 447 (92.2)

3.17 (2.03 – 4.94)

  Dry

234 / 297 (78.8)

1

  1. OR odds ratio, CI confidence interval, IPTp intermittent preventive treatment in pregnancy, AL artemether-lumefantrine, ASAQ artesunate-amodiaquine, MQAS mefloquine – artesunate, Hb hemoglobin, BMI body mass index.* Pooled placental malaria correspond to the presence of parasites and/or pigment in the placental.† missing data for one participant for symptomatic malaria at study start, treatment, and for two women for recurrent malaria